My reply to Noelle last week for those interested. "Thank you for your reply Noelle. It's good for me to know that, as you say, nothing that has fundamentally changed with the technology or the clinical trials. But unfortunately the reality is that your company stock has continually dropped for over 2 years and has dropped like a rock the past month and a half, losing over 50% of its value. I'm sure you will agree that's a huge drop, even for a bio-tech. And to drop like this on no news is odd and as an investor it has me worried. May I suggest your company issue a PR, stating what you told me, in an effort to settle the stock and bring back hope and confidence for the other shareholders? Also I would suggest including an estimate on any upcoming new trial data expected. It's been a very long time since new data has been released and that may also play into your company's drastic stock fall. Essentially it would be good for investors, and potential investors, to know that your company is working hard to be successful and has a good product that will one day save lives. Perhaps the lack of expediency is a reason your company value has dropped 90% over the past few years. You know how it goes, if you wait long enough, another person or company will come along with a better product, leaving yours obsolete. The world doesn't wait; it keeps moving forward. So if Advaxis truly does have a product which will save lives, let's get on with it and help these people because one day it could be you or me who needs it. Thank you."
I haven't had any reply from her yet and don't expect any.
